ORCID as entered in ROS
https://orcid.org/0000-0003-2971-0199
Select Publications
Conference Papers
, 2016, 'How a presentation to medical grand rounds on what makes a good dermatology consult improved efficiency of consultations?', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 60 - 60
, 2016, 'Novel specific therapies for epidermolysis bullosa', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 8 - 8
, 2016, 'The third case of digenic inheritance in KRT5 and KRT14 in epidermolysis bullosa simplex and 9 other novel keratin mutations in the Australian EB population', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 30 - 30
, 2014, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update (30-month) of the pivotal ERIVANCE BCC study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2014, 'Desmoglein 1 deficiency reveals a direct role for desmosomal dysfunction in allergic cutaneous reactions', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, NM, Albuquerque, pp. S73 - S73, presented at
, 2014, 'Translation and validation into Brazilian Portuguese of a quality of life instrument for epidermolysis bullosa patients (QOLEB)', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, CO, Denver, pp. AB149 - AB149, presented at
, 2014, 'Evaluation of safety and side-effect profile of Ingenol Mebutate (Picato) in a clinical setting', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 36 - 36
, 2013, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'A novel mutation in COL7A1, G2269R causing nail only DDEB and RDEB, with a presentation similar to TBDN at birth when coinherited with R2814X COL7A1 mutation', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SCOTLAND, Edinburgh, pp. S141 - S141, presented at
, 2013, 'Excellent reliability and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) compared to two other outcome measures', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SCOTLAND, Edinburgh, pp. S89 - S89, presented at
, 2013, 'Reliability study of four objective outcome measures for atopic dermatitis', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SCOTLAND, Edinburgh, pp. S102 - S102, presented at
, 2013, 'The development and validation of the TABQOL, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SCOTLAND, Edinburgh, pp. S37 - S37, presented at
, 2013, 'Translocation of the cytokine HMGB1 coincides with wound healing in fibroblast-injected wounds of recessive dystrophic epidermolysis bullosa', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SCOTLAND, Edinburgh, pp. S137 - S137, presented at
, 2013, 'A successful single-cycle rituximab treatment in radiation-induced pemphigus vulgaris with squamous cell carcinoma of the tongue and immunoglobulin G antibodies to desmocollins', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, FL, Miami Beach, pp. AB111 - AB111, presented at
, 2012, 'Flightless neutralizing antibodies improve healing of blistered skin', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, ITALY, Venice, pp. S9 - S9, presented at
, 2012, 'Technical loss of heterozygosity (TLOH) in mutation analysis by a SNP located in the primer binding site in two cases of epidermolysis bullosa (eb)', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, ITALY, Venice, pp. S98 - S98, presented at
, 2012, 'Inherited and acquired zinc deficiency disorders in dermatology revisited', in Australasian Journal of Dermatology, New South Wales : Wiley-Blackwell, Australia, pp. 39 - 40, presented at
, 2012, 'The organic anion transporter SLCO1B3 is regulated by type VII collagen expression in aggressive cutaneous squamous cell carcinoma', in BRITISH JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, ENGLAND, Exeter, pp. e25 - e25, presented at
, 2012, 'A review of the osteoporosis profile among epidermolysis bullosa patients', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 57 - 57
, 2011, 'Development of a disease-specific quality of life instrument for autoimmune bullous dermatoses: the ABQOL', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SPAIN, Barcelona, pp. S33 - S33, presented at
, 2011, 'Comprehensive survey of pregnancy and childbirth in epidermolysis bullosa reveals more blistering in EB newborns with dominant dystrophic EB and EB simplex delivered vaginally than by caesarian section', in Australasian Journal of Dermatology, New South Wales : Wiley-Blackwell, Australia, pp. 31 - 31, presented at
, 2011, 'Nail manifestations in autoimmune bullous disorders', in Australasian Journal of Dermatology, New South Wales : Wiley-Blackwell, Australia, pp. 22 - 22, presented at
, 2011, 'A case of classic (non-HIV related) Kaposi sarcoma complicated by lymphoedema that responded to vinblastin', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. A10 - A10
, 2010, 'First double-blind randomized clinical trial of intradermal allogeneic fibroblast therapy for severe generalized recessive dystrophic epidermolysis bullosa randomized against placebo injections resulted in similar wound healing that is independent of collagen VII expression', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, FINLAND, Helsinki, pp. S67 - S67, presented at
, 2010, 'Tumour microenvironment is implicated by dermal fibroblast expression profiling in the development of aggressive squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, FINLAND, Helsinki, pp. S83 - S83, presented at
, 2010, 'Mutations in WNT10A lead to the odonto-onycho-dermal dysplasia syndrome - the first Australian case', in EXPERIMENTAL DERMATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, AUSTRALIA, Cairns, pp. 589 - 589, presented at
, 2010, 'Dermal fibroblast expression profiling implicates tumour microenvironment in the development of aggressive squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa', in BRITISH JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, SCOTLAND, Edinburgh, pp. 948 - 948, presented at
, 2009, 'A comparison of Dermatology Life Quality index scores in a dermatology practice setting', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, CA, San Francisco, pp. AB94 - AB94, presented at
, 2009, 'Seborrheic keratoses appearing in sites of previous psoriasis plaques during responsive treatment with efalizumab', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, CA, San Francisco, pp. AB162 - AB162, presented at
, 2009, 'How to organize a ski and adventure camp for young patients with severe forms of epidermolysis bullosa', in Proceedings of the 3rd Asia International Conference on Modelling and Simulation (AMS 2009) Asia Modelling Symposium 2009, IEEE Computer Society Conference Publishing Services (CPS), pp. 13-18, Los Alamitos, CA, US, pp. AB5 - AB5, -
, 2009, 'Investigation of cell therapy for generalized severe recessive dystrophic epidermolysis bullosa by intradermal allogeneic fibroblasts randomized against placebo injections', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S28 - S28, -
, 2009, 'A novel keratin 5 splice site mutation in a Filipino family resulting in epidermolysis bullosa simplex associated with ankyloblepharon', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S47 - S47
, 2009, 'Cytoskeletal protein Flightless I affects Cellular Adhesion and Blister Formation in Epidermolysis Bullosa', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S79 - S79
, 2009, 'Gradual expression of plectin deficiency in a patient with epidermolysis bullosa simplex and adult-onset muscular dystrophy', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S51 - S51
, 2009, 'Outcomes of 10 pregnancies in three patients with recessive forms of epidermolysis bullosa', in Journal of the American Academy of Dermatology, St. Louis, Mo., Mosby, United States, pp. AB104 - AB104
, 2009, 'Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidemolysis bullosa in Australia', in Journal of the American Academy of Dermatology, St. Louis, Mo., Mosby, United States, pp. AB144 - AB144
, 2009, 'Seborrheic keratoses appearing in sites of previous psoriasis plaques during responsive treatment with efalizumab', in Proceedings - 2009 1st International Conference on Advances in Databases, Knowledge, and Data Applications, DBKDA 2009, pp. AB162 - AB162
, 2009, 'SLCO1B3 expression in recessive dystrophic epidermolysis bullosa associated squamous cell carcinoma is reduced by recombinant type VII collagen', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S55 - S55
, 2009, 'The Australasian epidermolysis bullosa registry', in Journal of the American Academy of Dermatology, St. Louis, Mo., Mosby, United States, pp. AB5 - AB5
, 2009, 'The use of tabular drug charts for diagnosis of complicated causes of cutaneous drug eruptions', in Journal of the American Academy of Dermatology, St. Louis, Mo., Mosby, United States, pp. AB43 - AB43
, 2008, 'A systematic review of the efficacy of probiotics for treating eczema', in Allergy, Blackwell Munksgaard, Copenhagen, Denmark, pp. 47 - 47, presented at
, 2008, 'Advances in the clinical assessment of autoimmune bullous disease: the development of a disease-specific quality of life instrument - the ABQOL', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2918 - 2918, presented at
, 2008, 'An intra-patient, prospective study of topical Gentian Violet for the treatment of chronic ulcers in non-Herlitz Junctional Epidermolysis Bullosa (nH-JEB)', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2917 - 2917, presented at
, 2008, 'Clinical outcomes of herlitz junctional epidermolysis bullosa infants: findings from the australasian epidermolysis bullosa registry', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2915 - 2915, presented at
, 2008, 'Quality of life evaluation in epidermolysis bullosa: development and results of the QOLEB questionnaire', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2911 - 2911, presented at
, 2008, 'Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2919 - 2919, presented at
, 2008, 'The development of a quality of life instrument specific for pemphigus', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2914 - 2914, presented at
, 2008, 'The Australasian Epidermolysis Bullosa Registry (AEBR)', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, TX, San Antonio, pp. AB86 - AB86, presented at
, 2008, 'FLIGHTLESS I, A NEGATIVE REGULATOR OF WOUND HEALING, AFFECTS CELLULAR ADHESION AND BLISTER FORMATION IN EPIDERMOLYSIS BULLOSA', in Wound Repair and Regeneration, Blackwell Publishing Inc, Malden, MA, USA, pp. A71 - A71, presented at
, 2008, 'Reactivity of LH7.2 and FNC1 antibodies against collagen VII does not predict the development of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S27 - S27, presented at
Filter by type
https://orcid.org/0000-0003-2971-0199